Professor James Kennedy
MRC bodies you are a member of:
- NMHB
Main form of employment:
- Centre for Addiction and Mental Health. Director, Neuroscience Research
Research group/department web page/s:
Personal remuneration:
- Honararia: Eli Lilly Corp
- Consulting to Roche Pharma Inc
Shareholdings and financial interests in companies
- None
Research income during current session [over £50k per grant]
- Kennedy JL, (PI) 01/10/11-30/09/16 $158,359 Cdn Canadian Institutes of Health Research (CIHR) Strategies for gene discovery in schizophrenia: subphenotypes, deep sequencing, and interactions. Role: PI 10%
- Kennedy JL (PI) Ministry of Research and Innovation 01/06/11/31/05/18 $2,780,000 Cdn CAMH Pharmacogenetics Program
- Levitan RD,(PI) Kennedy JL,(Co-Inves) et al 01/09/10-31/08/15 $152,626 Cdn Canadian Institutes of Health Research (CIHR) An Early Developmental Model of Overeating, Obesity and Executive Dysfunction Role: Co-PI 5
- R01 (NIMH, MH083643) Mulsant B, (PI) Kennedy JL (Co-PI) 07/01/09-06/30/14 $280,672 US National Institutes of Mental Health (NIMH) Incomplete Response in Late-Life Depression: Getting to Remission Role: Co-PI 5%
- MOP93543 Meaney M, (PI) Kennedy JL (Co-PI) 01/04/09-31/03/14 $172,331 Cdn Canadian Institutes of Health Research (CIHR) [Rank=1 in BSB cmttee] “The interaction of fetal development and genotype in determining neurocognitive development” Role: PI 5%
- MOP-93686 Levitan RD,(PI) Kennedy JL,(Co-Inves) 01/04/09-31/03/14 $156,087 Cdn Canadian Institutes of Health Research (CIHR) A Longitudinal Study of Food Reward and Obesity in Young Children: The Role of Gene-Environment Interaction Role: Co-PI 5%
- CBG-101925 Wells SL, (PI) Kennedy JL (Co-PI) et al 01/10/09-30/09/14 $299,686 Cdn Canadian Institutes of Health Research (CIHR) Emerging Team Grant: Co-morbidity of brain disorders and other health problems. The Ontario communities project: Using a mobile research laboratory to improve understanding, treatment and prevention of addiction and mental illness co-morbidities at the individual and community level
- MOP 97817 Zack MH (PI), Kennedy JL (Co-Inves) 01/10/09-30/09/12 $137.685 Cdn Canadian Institutes of Health Research (CIHR) Comparative effects of a D2 and mixed D1-D2 dopamine antagonist on gambling and amphetamine reinforcement in pathological gamblers and healthy controls Role: Co- Applicant 5%
- Kennedy, JL (PI) 01/03/09-28/02/10 $196,609 Cdn The Ontario Problem Gambling Research Centre (OPGRC) Investigation of Selected Signalling System Genes in Pathological Gambling Role: PI
- MOP 89853 Müller DJ (PI) Kennedy JL (Co-Inves) 01/10/08-30/09/13 $161,486 Cdn Canadian Institutes of Health Research (CIHR) Genetics of Antipsychotic-Induced Metabolic Syndrome Role: Co- Applicant 5%
- MOP 84391 Vincent J(PI) Kennedy JL (Co-Inves) 01/07/07-31/06/12 $189,300 Cdn Canadian Institutes of Health Research (CIHR ) Novel Strategies for Gene Discovery in Bipolar Disorder Role: Co- Applicant 5%
- MOP-86556 Koszycki D, Kennedy JL (Co-Inves) 04/01/08-03/30/13 $179,600 Cdn Canadian Institutes of Health Research (CIHR) “Children at risk for panic disorder” Role: Co-PI 5%
- Davis C(PI) Kennedy JL (Co-Inves) 01/07/07-31/06/10 $82,400 Cdn Canadian Institutes of Health Research (CIHR) Human Variation in Brain Reward Mechanism Role: Co- Applicant 5%
- MOP-15007 Kennedy JL (PI) 01/04/2006-30/3/10 $120,683 Cdn Canadian Institutes of Health Research (CIHR) “Strategies for Gene Discovery in Schizophrenia” Role: PI 10%
- 200508GMH Culotti JG (PI) Kennedy JL (Co-Inves) 01/11/2005-31/03/11 $93,000 Cdn Canadian Institutes of Health Research (CIHR) Neurodevelopmental Genetics of Human Psychiatric Disorders” Role Co-Applicant 5%
- RAA 79919 Busto UE, (PI) Kennedy JL (Co-PI) 01/04/06-31/12/10 $283,491 Cdn Canadian Institutes of Health Research (CIHR) Investigating comorbid substance use and psychiatric disorders: An integrated approach Role: Co-Applicant 5%
- MOP-79320 Harkness KL (PI) Kennedy JL (Co-Inves) 01/01/06-31/03/10 $128,588 Cdn Canadian Institutes of Health Research (CIHR) “The role of childhood adversity and genetic polymorphisms in the serotonin and BDNF system in the sensitization to stress in first onset major depression. “ Role: Co-Applicant 5%
- Richter MA, (PI) Kennedy JL (Co-PI) 01/04/07-31/03/09 $74,996 Cdn The Ontario Mental Health Foundation (OMHF) OCD: an innovative Genetics Study Utalizing Intermediate Phenotypes and Pharmacogenetics Role: Co-PI 5%
- Richter, MA, (PI) Kennedy JL (Co-PI) 15/07/08-15/04/09 $49,901 Cdn Obsessive Compulsive Foundation (OCF) Predicting Medication Response to OCD Role: Co-Applicant 5%
- MOP-16017 Meany M, (PI) Kennedy JL (Co-Applicant) 01/04/03-31/03/09 $75,000 Cdn Canadian Institutes of Health Research (CIHR) Maternal adversity, vulnerability and neurodevelopment” Role: PI 5%
Major academic collaborators [national and international]
- CRESTAR Study of Clozapine Response and Side Effects (David Collier, PI
Un-remunerated involvement with and membership of medical, bio-medical, pharmaceutical, healthcare provision or science or health policy/communication and similar activities/organisations
- OPTiMiSE: European group to study early psychosis – on Advisory Board
Political/pressure group associations:
- None
Family:
- None
